Cargando…

Cardiovascular disorders followed by SARS-CoV-2 infection: An inevitable challenge – Correspondence()

Detalles Bibliográficos
Autores principales:	Rouhani, Jalil, Keikha, Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359534/ https://www.ncbi.nlm.nih.gov/pubmed/35953019 http://dx.doi.org/10.1016/j.ijsu.2022.106830

Ejemplares similares

The past, present, and future of a silent multi-country human monkeypox outbreak 2022 – Correspondence
por: Rouhani, Jalil, et al.
Publicado: (2022)

Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations – Correspondence
por: Sahebi, Saeed, et al.
Publicado: (2022)

Deltacron is a recombinant variant of SARS-CoV-2 but not a laboratory mistake
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned?
por: Roohani, Jalil, et al.
Publicado: (2022)

Is sexual intercourse a major route of human Monkeypox transmission mode? – Correspondence
por: Keikha, Masoud
Publicado: (2022)

Human monkeypox coinfections; lessons from available cases – Correspondence
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Social networks and human monkeypox outbreak 2022: Hazards and opportunities – Correspondence
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence
por: Mandal, Mohanchandra, et al.
Publicado: (2022)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

Death-associated with human monkeypox outbreak 2022: the current perspectives – correspondence
por: Keikha, Masoud, et al.
Publicado: (2023)

Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

A commentary on ‘Advances in artificial intelligence (AI) based diagnosis and treatment of liver diseases – correspondence’
por: Abavisani, Mohammad, et al.
Publicado: (2023)

Post-SARS-CoV-2-vaccine shoulder pain: Is it relevant to the vaccine injection? – Correspondence
por: Deng, Zhenhan, et al.
Publicado: (2022)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant: Correspondence
por: Finsterer, Josef
Publicado: (2023)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Lee, Jaehyeon, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Mishra, Baijayantimala, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Eberhardt, Jens N, et al.
Publicado: (2020)

Probiotic as anti-colorectal cancer agents: Challenges and further perspective
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 – The first case reported in Portugal
por: Carbone, Ilma Floriana, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

Comments on “Disseminated Nocardia transvalensis complex and farcinica: First case in an immunocompetent”
por: Abavisani, Mohammad, et al.
Publicado: (2023)

Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2
por: Pfaff, Florian, et al.
Publicado: (2022)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ps1thaisre7i24uujr72b6g0s8